Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer

被引：0
|
作者：
Yolmo, Priyanka [1 ,2 ]
Siemens, D. Robert [1 ,2 ,3 ]
Koti, Madhuri [1 ,2 ,3 ]
机构：
[1] Queens Univ, Dept Biomed & Mol Sci, 99 Univ Ave, Kingston, ON K7L3N6, Canada
[2] Queens Univ, Canc Res Inst, Kingston, ON, Canada
[3] Queens Univ, Dept Urol, Kingston, ON, Canada
来源：
EUROPEAN UROLOGY | 2024年 / 85卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2023.12.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [21] MOLECULAR PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER
    Ragonese, Mauro
    Di Gianfrancesco, Luca
    Schinzari, Giovanni
    Palermo, Giuseppe
    Racioppi, Marco
    Bassi, PierFrancesco
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1024 - E1025
  • [22] Re: Pathological Response to Neoadjuvant Chemotherapy for Muscle-Invasive Micropapillary Bladder Cancer
    Wood, David P.
    JOURNAL OF UROLOGY, 2014, 191 (03): : 628 - 628
  • [23] Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    Zhang, Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 939 - +
  • [24] Re: Predicting the Pathologic Complete Response after Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2022, 207 (05): : 1154 - 1155
  • [25] Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Choi, S. J.
    Park, K. J.
    Heo, C.
    Park, B. W.
    Kim, M.
    Kim, J. K.
    CLINICAL RADIOLOGY, 2021, 76 (08) : 627.e13 - 627.e21
  • [26] Role of B7-H3 in predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Deol, Ekamjit S.
    Nabavizadeh, Reza
    Lavoie, Roxane R.
    Dumbrava, Mihai G.
    Horjeti, Edlira
    Thapa, Prabin
    Cheville, John C.
    Frank, Igor
    Lucien, Fabrice
    BJUI COMPASS, 2024, 5 (11): : 1052 - 1058
  • [27] Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
    Bejrananda, Tanan
    Saetang, Jirakrit
    Sangkhathat, Surasak
    BIOMEDICINES, 2023, 11 (01)
  • [28] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [29] Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer
    Li, Roger
    Spiess, Philippe E.
    Gilbert, Scott M.
    Necchi, Andrea
    EUROPEAN UROLOGY, 2019, 76 (01) : 4 - 6
  • [30] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
12345